EBIT: Income before interest and taxes.
Sunshine Biopharma, Inc. (SBFM) had EBIT of $-6.23M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$36.31M |
|
$-5.98M |
|
$24.05M |
|
$12.26M |
|
$42.53M |
|
$-6.23M |
|
$0.27M |
|
$-5.95M |
|
$-5.94M |
|
$-5.98M |
|
$-5.98M |
|
$-5.98M |
|
$-5.97M |
|
|
EBIT |
$-6.23M |
$-4.15M |
|
4.16M |
|
4.16M |
|
$-1.44 |
|
$-1.44 |
|
| Balance Sheet Financials | |
$26.85M |
|
$0.56M |
|
$3.23M |
|
$30.08M |
|
$6.44M |
|
-- |
|
$0.60M |
|
$7.04M |
|
$23.03M |
|
$21.15M |
|
$23.04M |
|
4.91M |
|
| Cash Flow Statement Financials | |
$-5.33M |
|
$-0.84M |
|
$4.75M |
|
$9.69M |
|
$9.12M |
|
$-0.56M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
33.76% |
|
-17.15% |
|
-17.15% |
|
-11.42% |
|
-16.40% |
|
-16.46% |
|
$-5.51M |
|
-- |
|
-- |
|
-- |
|
1.21 |
|
1.79 |
|
10.49 |
|
34.78 |
|
-25.95% |
|
-28.25% |
|
-19.87% |
|
-25.94% |
|
$4.70 |
|
$-1.32 |
|
$-1.28 |
|